Prognostic features of patients with myelodysplastic syndromes aged < 50 years: update of a single-institution experience

Authors:
  • PFPaola Finsinger
    Paola Finsinger
  • GLGiuseppina Loglisci
    Giuseppina Loglisci
  • MSMichelina Santopietro
    Michelina Santopietro
  • ASAdriano Salaroli
    Adriano Salaroli
  • ASAlessandra Serrao
    Alessandra Serrao
  • RLRoberto Latagliata
    Roberto Latagliata
  • PVPaola Volpicelli
    Paola Volpicelli
  • LPLuigi Petrucci
    Luigi Petrucci
  • MNMauro Nanni
    Mauro Nanni
  • GAGiuliana Alimena
    Giuliana Alimena

Abstract
Less than 10% of MDS patients are younger than 50 years. A series of 91 younger patients (median age 44 years with female prevalence) are reported and compared with elderly patients. Frequent karyotypic changes were trisomy 8 (10.5%) and monosomy 7 (5%). Twenty-three patients had occupational exposure to potential mutagens (benzene and solvents), with a male predominance, higher frequency of RCMD (52%) and higher frequency of monosomy 7 (13%). At a median follow-up of 72 months, 22 patients (24%) evolved to acute leukemia with higher frequency being observed among the exposed cohort (39% vs 19% of non-exposed). Unfavorable factors for overall survival were: age > 40 years, >5% of blasts and trilinear bone marrow involvement, intermediate-high WPSS risk. Present results suggest that younger MDS could be identified as a distinct subset: for patients belonging to low/intermediate-I risk, due to low transformation rate, aggressive approaches should rarely be recommended

This publication has 16 references indexed in Scilit: